Editas: 3Q Earnings Snapshot

November 7, 2018

CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $15.2 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of 32 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.

The genome editing company posted revenue of $14.5 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $6.6 million.

Editas shares have declined roughly 7 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $28.62, a climb of 24 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT

Update hourly